GlassScriptPhysician profile
Robert D Hudson, JR.
NPI 1164515011
$2,864.24
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $190 · 2021: $872 · 2022: $641 · 2023: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448 · Education: $82.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.53 |
| Education | $82.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $683.41 | 2019-2023 | Tremfya |
| Abbvie INC. | $409.86 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $324.70 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $269.99 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $247.68 | 2020-2021 | |
| Allergan, INC. | $209.98 | 2021 | |
| Lilly USA, LLC | $168.90 | 2019-2023 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $88.52 | 2022-2023 | Absorica Ld, Winlevi, Ilumya |
| Mallinckrodt Hospital Products INC. | $74.77 | 2023 | Terlivaz |
| Genzyme Corporation | $51.12 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $50.63 | 2021-2022 | |
| Pfizer INC. | $43.82 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.89 | 2022 | |
| Incyte Corporation | $30.84 | 2022-2023 | Opzelura |
| Galderma Laboratories, L.P. | $24.44 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aclaris Therapeutics, INC. | $20.42 | 2019 | |
| Amgen INC. | $19.00 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.19 | 2019 | |
| Ucb, INC. | $15.32 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.53 | 2022 | |
| Prugen, INC. Pharmaceuticals | $8.34 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.